. Author manuscript; available in PMC: 2016 Aug 1.

Published in final edited form as: Pharmacogenet Genomics. 2015 Aug;25(8):377–381. doi: 10.1097/FPC.0000000000000146

Table 2.

Changes in BMI body composition parameters at 6 months and 1 years of aromatase inhibitor therapy according to genotypes of the rs700518 polymorphism

	% Changes in BMI and Body Composition at 6 months			% Changes in BMI and Body Composition at one year
	GG (=18)	GA+AA N=(64)	P	GG (N=18)	GA+AA (N=64)	^*P
BMI	0.90±5.20	-0.41±7.78	0.44	1.62±8.92	0.25±8.12	0.53
Fat mass index	-2.48±6.39	-0.76±8.02	0.45	1.57±8.82	-1.13±8.30	0.23
Trunk fat mass index	-2.24±9.51	-2.20±10.43	0.99	4.63±11.73	-2.21±11.95	0.03
Fat-free mass index	0.19±2.92	0.29±4.81	0.94	-2.12±3.40	0.39±3.64	0.01

Values are Means±SD; BMI: body mass index;

T-test for BMI otherwise analysis of covariance adjusted for age